Tuesday, March 11, 2025 | 10:55 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Despite heroic work for Covid vaccine, pharma cos don't deserve affection

A financial analyst recently told that Pfizer's involvement in the coronavirus pandemic was about "as much public relations as it is a financial return

Photo: Reuters
Premium

Photo: Reuters

Stephen Buranyi | NYT
It’s about as near as science gets to a miracle: A coronavirus vaccine has arrived — and the main reason is that mRNA vaccines, a previously untested technology, appears to work better than almost anyone had hoped.

As recently as this summer, many analysts were pushing their predictions for a vaccine into the fall of 2021, in line with the timeline of traditional treatments. If these new vaccines perform as well in the wild as they have in clinical trials, the world will remember it as a victory perhaps greater than Salk and Sabin against polio. If this new type

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in